CARMIEL, Israel, Dec. 13, 2011 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX), announced today that Dr. David Aviezer, the Company's President and Chief Executive Officer, will present at the Oppenheimer 22nd Annual Healthcare Conference on Wednesday, December 14, 2011 at 3:55 PM ET. The conference will be held at The Waldorf-Astoria Hotel in New York City on December 13-14, 2011.
